GNTA – genenta science s.p.a. (US:NASDAQ)
Stock Stats
News
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
Genenta Science (NASDAQ:GNTA) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Genenta Science (NASDAQ:GNTA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
Form 6-K Genenta Science S.p.A. For: Oct 31
Form 424B5 Genenta Science S.p.A.
Form 6-K Genenta Science S.p.A. For: Oct 28
Form 6-K Genenta Science S.p.A. For: Oct 27
Form 6-K Genenta Science S.p.A. For: Jun 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.